Cleared Traditional

K171720 - encevis

K171720 is an FDA 510(k) clearance for encevis, manufactured by Ait Austrian Institute of Technology GmbH. The device is a Class 2 Neurology device with product code OMB cleared through the Traditional 510(k) pathway after a 311-day FDA review.

K171720 · Ait Austrian Institute of Technology GmbH · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2018
Decision
311d
Days
Class 2
Risk

K171720 is an FDA 510(k) clearance for the encevis. Classified as Automatic Event Detection Software For Full-montage Electroencephalograph (product code OMB), Class II - Special Controls.

Submitted by Ait Austrian Institute of Technology GmbH (Vienna, AT). The FDA issued a Cleared decision on April 19, 2018 after a review of 311 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Ait Austrian Institute of Technology GmbH devices

FDA 510(k) Submission Details - K171720

510(k) Number K171720 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 12, 2017
Decision Date April 19, 2018
Days to Decision 311 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
163d slower than avg
Panel avg: 148d · This submission: 311d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

OMB Device Classification - Class 2, Special Controls

Product Code OMB Automatic Event Detection Software For Full-montage Electroencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Automatically Mark Or Identify Electroencephalograph Waveforms For Spikes, Electrographic Seizures, Seizure-like Events In Order To Aid In Identification Of Such Events And Help Review And Annotation Of Prolonged Eeg Traces; All Output Subject To Verification By Qualified User
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Visamed GmbH
Arne Briest

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - OMB Automatic Event Detection Software For Full-montage Electroencephalograph

All 22
Devices cleared under the same product code (OMB) and FDA review panel - the closest regulatory comparables to K171720.
Natus NeuroWorks
K200878 · Natus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) · May 2020
Ceribell Pocket EEG Device
K191301 · Ceribell, Inc. · Sep 2019
Persyst 14 EEG Review and Analysis Software
K182181 · Persyst Development Corporation · Nov 2018
Natus NeuroWorks
K180421 · Natus Medical Incorporated Dba Excel-Tech Ltd. (Xltek) · Mar 2018
XLTEK CONNEX IP HEADBOX, MODEL 1054
K042223 · Excel Tech. , Ltd. · Sep 2004
EEG REAL PATIENT SPIKE AND EVENT DETECTOR MODULE, MODEL EX-SP-RP (PROPOSED)
K010085 · Excel Tech. , Ltd. · Mar 2001